Brief: Vivani Medical Receives Regulatory Approval To Initiate First In Human Clinical Trial With Glp-1 Implant In Obese And Overweight Individuals In Australia
26/09/2024 13:44
Sept 26 (Reuters) - Vivani Medical Inc VANI.O :
* VIVANI MEDICAL RECEIVES REGULATORY APPROVAL TO INITIATE
FIRST IN
HUMAN CLINICAL TRIAL WITH GLP-1 IMPLANT IN OBESE AND OVERWEIGHT
INDIVIDUALS IN AUSTRALIA
* VIVANI MEDICAL INC: TRIAL IS EXPECTED TO BE INITIATED
LATER THIS
YEAR WITH DATA PROJECTED TO BE AVAILABLE IN 2025
Source text for Eikon: ID:nBw5vChyPa
Further company coverage: VANI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vivani Medical
See all newsVivani Medical Q2 net loss narrows as expenses fall
Vivani Medical Inc reports results for the quarter ended June 30 - Earnings Summary
Vivani Medical Inc expected to post a loss of 8 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Vera Therapeutics, Vera Therapeutics, Nvidia
U.S. STOCKS ON THE MOVE-Revolution Medicines, Vivani Medical, Nvidia